The Research Center for Digestive Tract and Liver Diseases, Tel Aviv Medical Center, Tel Aviv, Israel.
Sackler Faculty of Medicine Tel-Aviv University, Tel Aviv, Israel.
J Crohns Colitis. 2019 Dec 10;13(12):1558-1568. doi: 10.1093/ecco-jcc/jjz086.
The pathogenesis of pouch inflammation may involve epithelial barrier disruption. We investigated whether faecal proteolytic activity is increased during pouchitis and results in epithelial barrier dysfunction through protease activating receptor [PAR] activation, and assessed whether the intestinal microbiome may be the source of the proteases.
Faecal samples were measured for protease activity using a fluorescein isothiocyanate [FITC]-casein florescence assay. Caco-2 cell monolayers were exposed to faecal supernatants to assess permeability to FITC-dextran. Tight junction protein integrity and PAR activation were assessed by immunoblot and immunofluorescence. A truncated PAR2 protein in Caco-2 cells was achieved by stable transfection using CRISPR/Cas9 plasmid. PAR2 activation in pouch biopsies was examined using antibodies directed to the N-terminus of the protein. Microbial composition was analysed based on 16S rRNA gene sequence analysis.
Ten pouchitis patients, six normal pouch [NP] patients and nine healthy controls [HC] were recruited. The pouchitis patients exhibited a 5.19- and 5.35-fold higher faecal protease [FP] activity [p ≤ 0.05] compared to the NP and HC participants, respectively. The genus Haemophilus was positively associated with FP activity [R = 0.718, false discovery rate < 0.1]. Faecal supernatants from pouchitis patients activated PAR2 on Caco-2 monolayers, disrupted tight junction proteins and increased epithelial permeability. PAR2 truncation in Caco-2 abrogated faecal protease-mediated permeability. Pouch biopsies obtained from pouchitis patients, but not from NP patients, displayed PAR2 activation.
Protease-producing bacteria may increase faecal proteolytic activity that results in pouch inflammation through disruption of tight junction proteins and increased epithelial permeability in a PAR2-dependent manner. This mechanism may initiate or propagate pouch inflammation.
pouch 炎的发病机制可能涉及上皮屏障破坏。我们研究了 pouchitis 期间粪便蛋白水解活性是否增加,并通过蛋白酶激活受体 [PAR] 激活导致上皮屏障功能障碍,并评估肠道微生物组是否可能是蛋白酶的来源。
使用荧光素异硫氰酸酯 [FITC]-酪蛋白荧光测定法测量粪便样品中的蛋白酶活性。将 Caco-2 细胞单层暴露于粪便上清液中,以评估 FITC-葡聚糖的通透性。通过免疫印迹和免疫荧光评估紧密连接蛋白完整性和 PAR 激活。通过使用 CRISPR/Cas9 质粒的稳定转染在 Caco-2 细胞中实现 PAR2 的截断。使用针对蛋白质 N 末端的抗体在 pouch 活检中检查 PAR2 激活。基于 16S rRNA 基因序列分析分析微生物组成。
招募了 10 名 pouchitis 患者、6 名正常 pouch [NP] 患者和 9 名健康对照 [HC]。与 NP 和 HC 参与者相比,pouchitis 患者的粪便蛋白酶 [FP] 活性分别高出 5.19 倍和 5.35 倍 [p≤0.05]。嗜血杆菌属与 FP 活性呈正相关 [R=0.718,假发现率 <0.1]。来自 pouchitis 患者的粪便上清液在 Caco-2 单层上激活 PAR2,破坏紧密连接蛋白并增加上皮通透性。在 Caco-2 中 PAR2 截断消除了粪便蛋白酶介导的通透性。来自 pouchitis 患者的 pouch 活检显示 PAR2 激活,但来自 NP 患者的活检没有。
产蛋白酶的细菌可能通过破坏紧密连接蛋白和增加上皮通透性以 PAR2 依赖性方式增加粪便蛋白水解活性,从而导致 pouch 炎症。这种机制可能引发或传播 pouch 炎症。